Prevalença crua
Evolució temporal de la prevalença crua en funció del grups de fragilitat per sexe, edat i Regió Sanitària.
El grup de No fràgil inclou Robust i Prefràgil.
El grup de Fràgil inclou Fragilitat moderada i Fragilitat severa.
General
2 grups de fragilitat
| No fràgil (0 - 8) |
1,246,677 (88.1%) |
1,249,321 (86.8%) |
1,254,038 (85.6%) |
1,271,004 (85.9%) |
1,312,783 (83.9%) |
| Fràgil (>9) |
168,966 (11.9%) |
190,208 (13.2%) |
211,274 (14.4%) |
208,820 (14.1%) |
251,828 (16.1%) |
4 grups de fragilitat
| Robust (0 - 4) |
770,643 (54.4%) |
764,834 (53.1%) |
760,555 (51.9%) |
780,597 (52.7%) |
797,479 (51.0%) |
| Prefràgil (5 - 8) |
476,034 (33.6%) |
484,487 (33.7%) |
493,483 (33.7%) |
490,407 (33.1%) |
515,304 (32.9%) |
| Fragilitat moderada (9 - 11) |
124,229 (8.8%) |
135,540 (9.4%) |
146,256 (10.0%) |
144,709 (9.8%) |
167,379 (10.7%) |
| Fragilitat severa (>12) |
44,737 (3.2%) |
54,668 (3.8%) |
65,018 (4.4%) |
64,111 (4.3%) |
84,449 (5.4%) |
Prevalença crua per sexe
2 grups de fragilitat
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
113,792 (14.1%) |
127,230 (15.5%) |
140,793 (16.9%) |
139,469 (16.6%) |
165,370 (18.7%) |
55,174 (9.1%) |
62,978 (10.2%) |
70,481 (11.2%) |
69,351 (10.9%) |
86,458 (12.8%) |
| No fràgil (0 - 8) |
695,603 (85.9%) |
694,384 (84.5%) |
694,337 (83.1%) |
703,073 (83.4%) |
721,329 (81.3%) |
551,074 (90.9%) |
554,937 (89.8%) |
559,701 (88.8%) |
567,931 (89.1%) |
591,454 (87.2%) |
4 grups de fragilitat
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
414,743 (51.2%) |
410,812 (50.0%) |
407,536 (48.8%) |
418,781 (49.7%) |
425,863 (48.0%) |
355,900 (58.7%) |
354,022 (57.3%) |
353,019 (56.0%) |
361,816 (56.8%) |
371,616 (54.8%) |
| Prefràgil (5 - 8) |
280,860 (34.7%) |
283,572 (34.5%) |
286,801 (34.3%) |
284,292 (33.7%) |
295,466 (33.3%) |
195,174 (32.2%) |
200,915 (32.5%) |
206,682 (32.8%) |
206,115 (32.3%) |
219,838 (32.4%) |
| Fragilitat moderada (9 - 11) |
82,046 (10.1%) |
88,678 (10.8%) |
95,203 (11.4%) |
94,266 (11.2%) |
107,030 (12.1%) |
42,183 (7.0%) |
46,862 (7.6%) |
51,053 (8.1%) |
50,443 (7.9%) |
60,349 (8.9%) |
| Fragilitat severa (>12) |
31,746 (3.9%) |
38,552 (4.7%) |
45,590 (5.5%) |
45,203 (5.4%) |
58,340 (6.6%) |
12,991 (2.1%) |
16,116 (2.6%) |
19,428 (3.1%) |
18,908 (3.0%) |
26,109 (3.9%) |
Prevalença crua per edat
2 grups de fragilitat
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
8,416 (2.2%) |
9,468 (2.5%) |
10,899 (2.8%) |
11,092 (2.8%) |
12,841 (3.2%) |
14,539 (4.3%) |
16,832 (4.8%) |
19,290 (5.4%) |
18,654 (5.3%) |
21,468 (5.9%) |
| No fràgil (0 - 8) |
374,925 (97.8%) |
371,569 (97.5%) |
372,603 (97.2%) |
380,358 (97.2%) |
390,557 (96.8%) |
322,843 (95.7%) |
332,717 (95.2%) |
336,508 (94.6%) |
334,659 (94.7%) |
340,623 (94.1%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
19,386 (8.2%) |
23,256 (9.2%) |
28,555 (10.3%) |
27,667 (9.9%) |
32,789 (10.9%) |
48,863 (21.8%) |
51,867 (24.3%) |
53,087 (26.9%) |
52,436 (25.8%) |
57,350 (27.8%) |
| No fràgil (0 - 8) |
216,159 (91.8%) |
228,877 (90.8%) |
248,950 (89.7%) |
252,953 (90.1%) |
266,871 (89.1%) |
174,997 (78.2%) |
161,510 (75.7%) |
144,235 (73.1%) |
150,536 (74.2%) |
149,137 (72.2%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
46,140 (30.6%) |
52,333 (33.7%) |
57,934 (36.5%) |
56,794 (36.2%) |
68,392 (39.3%) |
24,515 (37.0%) |
28,103 (41.0%) |
31,555 (44.1%) |
32,057 (43.9%) |
43,191 (48.7%) |
| No fràgil (0 - 8) |
104,764 (69.4%) |
103,068 (66.3%) |
100,615 (63.5%) |
100,225 (63.8%) |
105,441 (60.7%) |
41,809 (63.0%) |
40,523 (59.0%) |
40,011 (55.9%) |
40,914 (56.1%) |
45,483 (51.3%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
7,107 (38.9%) |
8,349 (43.0%) |
9,954 (47.2%) |
10,120 (47.1%) |
15,797 (51.8%) |
| No fràgil (0 - 8) |
11,180 (61.1%) |
11,057 (57.0%) |
11,116 (52.8%) |
11,359 (52.9%) |
14,671 (48.2%) |
4 grups de fragilitat
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
291,126 (75.9%) |
286,405 (75.2%) |
284,760 (74.3%) |
293,556 (75.0%) |
298,862 (74.1%) |
221,623 (65.7%) |
224,949 (64.4%) |
223,884 (62.9%) |
226,380 (64.1%) |
228,441 (63.1%) |
| Prefràgil (5 - 8) |
83,799 (21.9%) |
85,164 (22.4%) |
87,843 (22.9%) |
86,802 (22.2%) |
91,695 (22.7%) |
101,220 (30.0%) |
107,768 (30.8%) |
112,624 (31.7%) |
108,279 (30.6%) |
112,182 (31.0%) |
| Fragilitat moderada (9 - 11) |
7,345 (1.9%) |
8,213 (2.2%) |
9,273 (2.4%) |
9,480 (2.4%) |
10,744 (2.7%) |
12,320 (3.7%) |
14,008 (4.0%) |
15,842 (4.5%) |
15,305 (4.3%) |
17,350 (4.8%) |
| Fragilitat severa (>12) |
1,071 (0.3%) |
1,255 (0.3%) |
1,626 (0.4%) |
1,612 (0.4%) |
2,097 (0.5%) |
2,219 (0.7%) |
2,824 (0.8%) |
3,448 (1.0%) |
3,349 (0.9%) |
4,118 (1.1%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
128,084 (54.4%) |
133,623 (53.0%) |
142,044 (51.2%) |
147,005 (52.4%) |
153,168 (51.1%) |
70,509 (31.5%) |
63,385 (29.7%) |
55,537 (28.1%) |
59,269 (29.2%) |
58,460 (28.3%) |
| Prefràgil (5 - 8) |
88,075 (37.4%) |
95,254 (37.8%) |
106,906 (38.5%) |
105,948 (37.8%) |
113,703 (37.9%) |
104,488 (46.7%) |
98,125 (46.0%) |
88,698 (45.0%) |
91,267 (45.0%) |
90,677 (43.9%) |
| Fragilitat moderada (9 - 11) |
15,607 (6.6%) |
18,446 (7.3%) |
22,163 (8.0%) |
21,580 (7.7%) |
25,013 (8.3%) |
36,002 (16.1%) |
37,098 (17.4%) |
36,819 (18.7%) |
36,589 (18.0%) |
38,816 (18.8%) |
| Fragilitat severa (>12) |
3,779 (1.6%) |
4,810 (1.9%) |
6,392 (2.3%) |
6,087 (2.2%) |
7,776 (2.6%) |
12,861 (5.7%) |
14,769 (6.9%) |
16,268 (8.2%) |
15,847 (7.8%) |
18,534 (9.0%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
39,475 (26.2%) |
37,558 (24.2%) |
35,893 (22.6%) |
35,857 (22.8%) |
37,319 (21.5%) |
15,475 (23.3%) |
14,660 (21.4%) |
14,277 (19.9%) |
14,338 (19.6%) |
15,882 (17.9%) |
| Prefràgil (5 - 8) |
65,289 (43.3%) |
65,510 (42.2%) |
64,722 (40.8%) |
64,368 (41.0%) |
68,122 (39.2%) |
26,334 (39.7%) |
25,863 (37.7%) |
25,734 (36.0%) |
26,576 (36.4%) |
29,601 (33.4%) |
| Fragilitat moderada (9 - 11) |
31,759 (21.0%) |
34,673 (22.3%) |
36,978 (23.3%) |
36,181 (23.0%) |
41,798 (24.0%) |
16,351 (24.7%) |
17,769 (25.9%) |
19,209 (26.8%) |
19,444 (26.6%) |
24,577 (27.7%) |
| Fragilitat severa (>12) |
14,381 (9.5%) |
17,660 (11.4%) |
20,956 (13.2%) |
20,613 (13.1%) |
26,594 (15.3%) |
8,164 (12.3%) |
10,334 (15.1%) |
12,346 (17.3%) |
12,613 (17.3%) |
18,614 (21.0%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
4,351 (23.8%) |
4,254 (21.9%) |
4,160 (19.7%) |
4,192 (19.5%) |
5,347 (17.5%) |
| Prefràgil (5 - 8) |
6,829 (37.3%) |
6,803 (35.1%) |
6,956 (33.0%) |
7,167 (33.4%) |
9,324 (30.6%) |
| Fragilitat moderada (9 - 11) |
4,845 (26.5%) |
5,333 (27.5%) |
5,972 (28.3%) |
6,130 (28.5%) |
9,081 (29.8%) |
| Fragilitat severa (>12) |
2,262 (12.4%) |
3,016 (15.5%) |
3,982 (18.9%) |
3,990 (18.6%) |
6,716 (22.0%) |
Prevalença crua per Regió Sanitaria
2 grups de fragilitat
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
1,332 (9.6%) |
1,492 (10.6%) |
1,678 (11.8%) |
1,633 (11.5%) |
2,075 (13.8%) |
116,095 (12.5%) |
130,563 (13.8%) |
145,180 (15.1%) |
143,161 (14.8%) |
172,021 (16.8%) |
| No fràgil (0 - 8) |
12,515 (90.4%) |
12,536 (89.4%) |
12,523 (88.2%) |
12,584 (88.5%) |
13,011 (86.2%) |
812,329 (87.5%) |
813,742 (86.2%) |
816,457 (84.9%) |
827,103 (85.2%) |
852,916 (83.2%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
8,457 (8.0%) |
9,656 (8.9%) |
10,919 (9.9%) |
10,978 (9.7%) |
13,320 (11.1%) |
12,794 (12.6%) |
14,479 (14.1%) |
16,088 (15.4%) |
15,676 (15.0%) |
19,119 (17.2%) |
| No fràgil (0 - 8) |
97,407 (92.0%) |
98,627 (91.1%) |
99,860 (90.1%) |
101,958 (90.3%) |
106,492 (88.9%) |
88,420 (87.4%) |
88,419 (85.9%) |
88,274 (84.6%) |
88,901 (85.0%) |
91,767 (82.8%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
16,004 (10.4%) |
17,997 (11.5%) |
19,828 (12.4%) |
19,612 (12.1%) |
23,953 (13.9%) |
9,940 (13.8%) |
11,130 (15.3%) |
12,169 (16.5%) |
12,139 (16.3%) |
14,547 (18.5%) |
| No fràgil (0 - 8) |
138,332 (89.6%) |
138,908 (88.5%) |
140,154 (87.6%) |
142,993 (87.9%) |
148,352 (86.1%) |
62,207 (86.2%) |
61,827 (84.7%) |
61,622 (83.5%) |
62,195 (83.7%) |
64,048 (81.5%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
| Fràgil (>9) |
4,344 (10.9%) |
4,891 (12.2%) |
5,412 (13.3%) |
5,621 (13.7%) |
6,793 (15.8%) |
| No fràgil (0 - 8) |
35,467 (89.1%) |
35,262 (87.8%) |
35,148 (86.7%) |
35,270 (86.3%) |
36,197 (84.2%) |
4 grups de fragilitat
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
7,987 (57.7%) |
7,889 (56.2%) |
7,704 (54.2%) |
7,771 (54.7%) |
7,974 (52.9%) |
496,616 (53.5%) |
491,636 (52.1%) |
487,674 (50.7%) |
500,198 (51.6%) |
509,547 (49.7%) |
| Prefràgil (5 - 8) |
4,528 (32.7%) |
4,647 (33.1%) |
4,819 (33.9%) |
4,813 (33.9%) |
5,037 (33.4%) |
315,713 (34.0%) |
322,106 (34.1%) |
328,783 (34.2%) |
326,905 (33.7%) |
343,369 (33.5%) |
| Fragilitat moderada (9 - 11) |
1,043 (7.5%) |
1,139 (8.1%) |
1,251 (8.8%) |
1,215 (8.5%) |
1,491 (9.9%) |
83,615 (9.0%) |
91,318 (9.7%) |
98,797 (10.3%) |
97,905 (10.1%) |
112,795 (11.0%) |
| Fragilitat severa (>12) |
289 (2.1%) |
353 (2.5%) |
427 (3.0%) |
418 (2.9%) |
584 (3.9%) |
32,480 (3.5%) |
39,245 (4.2%) |
46,383 (4.8%) |
45,256 (4.7%) |
59,226 (5.8%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
68,581 (64.8%) |
69,250 (64.0%) |
69,858 (63.1%) |
71,853 (63.6%) |
74,397 (62.1%) |
52,076 (51.5%) |
52,008 (50.5%) |
51,784 (49.6%) |
52,774 (50.5%) |
54,038 (48.7%) |
| Prefràgil (5 - 8) |
28,826 (27.2%) |
29,377 (27.1%) |
30,002 (27.1%) |
30,105 (26.7%) |
32,095 (26.8%) |
36,344 (35.9%) |
36,411 (35.4%) |
36,490 (35.0%) |
36,127 (34.5%) |
37,729 (34.0%) |
| Fragilitat moderada (9 - 11) |
6,627 (6.3%) |
7,184 (6.6%) |
7,930 (7.2%) |
7,877 (7.0%) |
9,207 (7.7%) |
9,802 (9.7%) |
10,717 (10.4%) |
11,472 (11.0%) |
11,085 (10.6%) |
13,011 (11.7%) |
| Fragilitat severa (>12) |
1,830 (1.7%) |
2,472 (2.3%) |
2,989 (2.7%) |
3,101 (2.7%) |
4,113 (3.4%) |
2,992 (3.0%) |
3,762 (3.7%) |
4,616 (4.4%) |
4,591 (4.4%) |
6,108 (5.5%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
89,591 (58.0%) |
89,578 (57.1%) |
89,795 (56.1%) |
92,908 (57.1%) |
95,728 (55.6%) |
36,118 (50.1%) |
35,167 (48.2%) |
34,717 (47.0%) |
35,685 (48.0%) |
36,116 (46.0%) |
| Prefràgil (5 - 8) |
48,741 (31.6%) |
49,330 (31.4%) |
50,359 (31.5%) |
50,085 (30.8%) |
52,624 (30.5%) |
26,089 (36.2%) |
26,660 (36.5%) |
26,905 (36.5%) |
26,510 (35.7%) |
27,932 (35.5%) |
| Fragilitat moderada (9 - 11) |
12,278 (8.0%) |
13,389 (8.5%) |
14,339 (9.0%) |
14,176 (8.7%) |
16,536 (9.6%) |
7,418 (10.3%) |
8,009 (11.0%) |
8,407 (11.4%) |
8,288 (11.1%) |
9,496 (12.1%) |
| Fragilitat severa (>12) |
3,726 (2.4%) |
4,608 (2.9%) |
5,489 (3.4%) |
5,436 (3.3%) |
7,417 (4.3%) |
2,522 (3.5%) |
3,121 (4.3%) |
3,762 (5.1%) |
3,851 (5.2%) |
5,051 (6.4%) |
| e-SIF |
2017 |
2018 |
2019 |
2020 |
2021 |
| Robust (0 - 4) |
19,674 (49.4%) |
19,306 (48.1%) |
19,023 (46.9%) |
19,408 (47.5%) |
19,679 (45.8%) |
| Prefràgil (5 - 8) |
15,793 (39.7%) |
15,956 (39.7%) |
16,125 (39.8%) |
15,862 (38.8%) |
16,518 (38.4%) |
| Fragilitat moderada (9 - 11) |
3,446 (8.7%) |
3,784 (9.4%) |
4,060 (10.0%) |
4,163 (10.2%) |
4,843 (11.3%) |
| Fragilitat severa (>12) |
898 (2.3%) |
1,107 (2.8%) |
1,352 (3.3%) |
1,458 (3.6%) |
1,950 (4.5%) |
Torna a dalt
